News
Roche licenses vemurafenib to Chugai
F Hoffmann-La Roche has given marketing and development rights of BRAF inhibitor vemurafenib to Chugai Pharmaceutical. The licensing deal allows Roche to...
News
Mylan Pharma rolls out generic benign prostatic hyperplasia drug
Mylan Pharmaceuticals has introduced Alfuzosin Hydrochloride Extended-release Tablets, 10mg.Mylan's Alfuzosin Hydrochloride Extended-release Tablets, 10mg are generic equivalent to Uroxatral, indicated for the treatment of signs...
News
Anacor develops first candidate under Lilly pact
Anacor Pharmaceuticals has developed the first candidate under its animal health research agreement with Eli Lilly.Under the contract, the companies will explore the usage of...
News
Majority UK oncologists prefer Doctors.net.uk
Almost 51% of the Oncologists in the UK are said to be using online cancer research center, Doctors.net.uk.The center offers all news, information and research...
News
Adec, Zuellig Pharma in Pharma KPO joint venture
Adec Solutions, a part of the Adec Group of Companies, has collaborated with Zuellig Pharma to built a pharmaceutical and healthcare-focused knowledge process outsourcing (KPO)...
News
Eteplirsen Shows Efficacy for Duchenne Muscular Dystrophy
AVI BioPharma has reported positive Phase Ib/II study results of eteplirsen, an exon-skipping therapy for the treatment of Duchenne muscular dystrophy. The...
News
International Space Station Provides Pharmaceutical Insight
The International Space Station could be used to develop pharmaceutical products, including treatments for muscular dystrophy. The multilateral coordination board for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.